...
首页> 外文期刊>Pharmacological reviews >International Union of Basic and Clinical Pharmacology. XC. Multisite Pharmacology:Recommendations for the Nomenclature of Receptor Allosterism and Allosteric Ligands
【24h】

International Union of Basic and Clinical Pharmacology. XC. Multisite Pharmacology:Recommendations for the Nomenclature of Receptor Allosterism and Allosteric Ligands

机译:国际基础和临床药理学联盟。 XC。多部位药理学:受体变构和配体配体的命名建议

获取原文
获取原文并翻译 | 示例

摘要

Allosteric interactions play vital roles in metabolic processes and signal transduction and, more recently, have become the focus of numerous pharmacological studies because of the potential for discovering more target-selective chemical probes and therapeutic agents. In addition to classic early studies on enzymes, there are now examples of small molecule allosteric modulators for all superfamilies of receptors encoded by the genome, including ligand- and voltage-gated ion channels,G protein-coupled receptors, nuclear hormone receptors, and receptor tyrosine kinases. As a consequence, a vast array of pharmacologic behaviors has been ascribed to allosteric ligands that can vary in a target-, ligand-, and cell-/tissue-dependent manner. The current article presents an overview of allostery as applied to receptor families and approaches for detecting and validating allosteric interactions and gives recommendations for the nomenclature of allosteric ligands and their properties.
机译:变构相互作用在代谢过程和信号转导中起着至关重要的作用,最近,由于发现更多靶标选择性化学探针和治疗剂的潜力,它已成为众多药理研究的重点。除了经典的酶研究外,现在还有一些小分子变构调节剂的例子,它们适用于基因组编码的受体的所有超家族,包括配体和电压门控离子通道,G蛋白偶联受体,核激素受体和受体酪氨酸激酶。结果,已经将多种药理学行为归因于可以以靶标,配体和细胞/组织依赖性方式变化的变构配体。本文介绍了应用于受体家族的变构作用的概述以及用于检测和验证变构作用的方法,并提出了对变构配体的命名及其性质的建议。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号